Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Belec

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
AIDS (London, England)|April 26, 2000
Phenotypic resistance to protease inhibitors in patients who fail on highly active antiretroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenzC Piketty, E Race, P Castiel, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 25, 2015
Variability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2J LeGoff, P Roques, M-A Jenabian, et al.
AIDS (London, England)|October 31, 2001
Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patientsA Landau, D Batisse, C Piketty, et al.
AIDS (London, England)|June 6, 2000
Efficacy and safety of combination therapy with interferon-alpha2b and ribavirin for chronic hepatitis C in HIV-infected patientsA Landau, D Batisse, J P Duong Van Huyen, et al.
AIDS (London, England)|June 10, 1998
Discrepant responses to triple combination antiretroviral therapy in advanced HIV diseaseC Piketty, P Castiel, L Belec, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2005
Interactions between human immunodeficiency virus and herpes viruses within the oral mucosaF X Mbopi-Keou, R E Mbu, H Gonsu Kamga, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
AIDS (London, England)|April 26, 2000
Phenotypic resistance to protease inhibitors in patients who fail on highly active antiretroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenzC Piketty, E Race, P Castiel, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 25, 2015
Variability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2J LeGoff, P Roques, M-A Jenabian, et al.
AIDS (London, England)|October 31, 2001
Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patientsA Landau, D Batisse, C Piketty, et al.
AIDS (London, England)|June 6, 2000
Efficacy and safety of combination therapy with interferon-alpha2b and ribavirin for chronic hepatitis C in HIV-infected patientsA Landau, D Batisse, J P Duong Van Huyen, et al.
AIDS (London, England)|June 10, 1998
Discrepant responses to triple combination antiretroviral therapy in advanced HIV diseaseC Piketty, P Castiel, L Belec, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2005
Interactions between human immunodeficiency virus and herpes viruses within the oral mucosaF X Mbopi-Keou, R E Mbu, H Gonsu Kamga, et al.
Pageof 8